- Home
- CGEN vs FULTP Comparison
CGEN vs FULTP Comparison
Compare CGEN & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGEN | FULTP |
|---|---|---|
| Founded | 1993 | N/A |
| Country | Israel | United States |
| Employees | N/A | 3400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.3M | N/A |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGEN | FULTP |
|---|---|---|
| Price | $1.52 | $19.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 278.6K | N/A |
| Earning Date | 11-10-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,903,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $231.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | N/A |
| 52 Week High | $2.66 | N/A |
Technical Indicators
Market Signals| Indicator | CGEN | FULTP |
|---|---|---|
| Relative Strength Index (RSI) | 43.59 | 38.75 |
| Support Level | $1.47 | $19.00 |
| Resistance Level | $1.72 | $19.43 |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 24.01 | 13.33 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.